Molecular and Cellular Biochemistry

, Volume 233, Issue 1, pp 165–173

Expression of atrial natriuretic peptide receptor-A antagonizes the mitogen-activated protein kinases (Erk2 and P38MAPK) in cultured human vascular smooth muscle cells

  • Guru Dutt Sharma
  • Huong T. Nguyen
  • Alexander S. Antonov
  • Ross G. Gerrity
  • Thomas von Geldern
  • Kailash N. Pandey
Article

DOI: 10.1023/A:1015882302796

Cite this article as:
Sharma, G.D., Nguyen, H.T., Antonov, A.S. et al. Mol Cell Biochem (2002) 233: 165. doi:10.1023/A:1015882302796

Abstract

To understand the signaling mechanisms of atrial natriuretic peptide (ANP) receptor-A (NPRA), we studied the effect of the ANP/NPRA system on mitogen-activated protein kinases (MAPKs), with particular emphasis on the extracellular-regulated kinase (Erk2) and stress-activated protein kinase (p38MAPK) in cultured human vascular smooth muscle cells (HVSMC). Angiotensin II (ANG II) and platelet-derived growth factor (PDGF) stimulated the immunoreactive Erk2 and p38MAPK activities and their protein levels by 2–4 fold. The pretreatment of cells with ANP significantly inhibited the agonist-stimulated Erk2 and p38MAPK activities and protein expression by 65–75% in HVSMC transiently transfected with NPRA, as compared with only 18–22% inhibition in vector-transfected cells. The pretreatment of cells with KT5823, an inhibitor of cGMP-dependent protein kinase (PKG), reversed the inhibitory effects of ANP on MAPK activities and protein expression by 90–95%. PD98059, which inhibits Erk2 by directly inhibiting the MAPK-kinase (MEK), and SB202192, a selective antagonist of p38MAPK, blocked the Erk2 and p38MAPK activities, respectively. Interestingly, ANP stimulated the MAPK-phosphatase-3 (MKP-3) protein levels by more than 3-fold in HVSMC over-expressing NPRA, suggesting that ANP-dependent inhibition of MAPKs may also proceed by stimulating the phosphatase cascade. These present findings provide the evidence that ANP exerts inhibitory effects on agonist-stimulated MAPKs (Erk2 and p38MAPK) activities and protein levels in a 2-fold manner: by antagonizing the upstream signaling pathways and by activation of MKP-3 to counter-regulate MAPKs in a cGMP and PKG-dependent manner. Our results identify a signal transduction pathway in HVSMC that could contribute to vascular remodeling and structural changes in human hypertension.

atrial natruinetic peptide receptor-A mitogen-activated protein kinases (Erk2 and p38MAPKhuman vascular smooth muscle cells MAPK phosphatase 

Copyright information

© Kluwer Academic Publishers 2002

Authors and Affiliations

  • Guru Dutt Sharma
  • Huong T. Nguyen
  • Alexander S. Antonov
  • Ross G. Gerrity
  • Thomas von Geldern
  • Kailash N. Pandey

There are no affiliations available

Personalised recommendations